Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Taha Kadi"'
Autor:
Abrar Al-Sheikh, Mohammed Zawiah, Daniah Alshamaseen, Al-Motassem Yousef, Taha Kadi, Rand Farhad
Publikováno v:
Cancer Chemotherapy and Pharmacology. 83:755-762
Acute lymphoblastic leukemia (ALL) is one of the major malignancies affecting children in Jordan. Methotrexate (MTX) is the cornerstone of chemotherapy for ALL, and works by targeting enzymes involved in the folate pathway. We hypothesize that geneti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86bf0193b7c0d80fc21e3699bdfb9245
https://doi.org/10.1007/s00280-019-03776-8
https://doi.org/10.1007/s00280-019-03776-8
Autor:
Taha Kadi, Ramzi Mukred, Sayida Al-Jamei, Mohammed Zawiah, Rana Abu Farha, Abdulrhman Al-Baidani
Publikováno v:
Journal of Pharmaceutical Health Services Research. 10:67-72
Objective The current study aims to assess Yemeni pharmacists’ knowledge, attitude and practice of adverse drug reactions (ADRs) reporting systems and to determine barriers hindering them from reporting. Methods A cross-sectional descriptive study
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1ed4342175b158486ef862beebd36a79
https://doi.org/10.1111/jphs.12257
https://doi.org/10.1111/jphs.12257
Publikováno v:
Journal of Evaluation in Clinical Practice. 25:585-590
RATIONAL, AIMS, AND OBJECTIVE The aim of this study was to assess the knowledge and perception towards evidence-based practice (EBP) and identify the perceived barriers to practicing EBP among Yemeni pharmacists and pharmacy technicians. METHODS A cr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6eb6cb1480a2fdf8da3bffa174d8866b
https://doi.org/10.1111/jep.12988
https://doi.org/10.1111/jep.12988
Autor:
Al-Motassem Yousef, Hanguin M Al-Ramadhani, Shorouq Al-Yacoub, Dua’ a Tantawi, Taha Kadi, Mohammed Zawiah
Publikováno v:
Cancer Chemotherapy and Pharmacology. 82:237-243
Colorectal cancer (CRC) is one of the major health issues worldwide. 5-Fluorouracil (5-FU) is a cornerstone of chemotherapy for CRC and the major targets of 5-FU are folate-metabolizing enzymes. A total of 103 CRC patients with complete clinical data
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c2f39a475cbeee2ce203820dc7bff226
https://doi.org/10.1007/s00280-018-3608-6
https://doi.org/10.1007/s00280-018-3608-6
Autor:
Derya Erisik, Berrin Ozdil, Eda Acikgoz, Cemile Sinem Asker Abdikan, Taha Kadir Yesin, Huseyin Aktug
Publikováno v:
ACS Omega, Vol 8, Iss 33, Pp 30145-30157 (2023)
Externí odkaz:
https://doaj.org/article/aba0fb7a193b425ebfadded91f58525d
Autor:
Rasha Al-Hiary, Mohammed Zawiah, Shorouq Al-Yacoub, Khalil Majdalawi, Abdel Rahman Ajaj, Dua’a Tantawi, Mohammed Yousef, Ramzi Mukred, Al-Motassem Yousef, Taha Kadi
Publikováno v:
Drug metabolism and personalized therapy. 33(4)
Background Early relapse in colorectal cancer (CRC) after curative resection is mainly attributed to the key determinants such as tumor histology, stage, lymphovascular invasion, and the response to chemotherapy. Case presentation Interindividual var
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad13a99ab288864eef7f7997fe9dc5e7
https://pubmed.ncbi.nlm.nih.gov/30207288
https://pubmed.ncbi.nlm.nih.gov/30207288